U.S. President Donald Trump will meet on Thursday with chief executives from major drugmakers, a White House official ...
The Prescription Drug Affordability Act would aim to stop pharmacy benefit managers, or PBMs, from “exploiting loopholes” to ...
The Arkansas General Assembly gaveled in a new legislative session last month in Little Rock and members of both the House ...
Pharmacy benefits managers, or PBMs, are meant to act as a middleman between drug manufacturers and insurance companies to ...
Senate Study Bill 1051 would shield agricultural chemical companies like Bayer, which produces the glyphosate-based herbicide ...
U.S. President Donald Trump is set to meet with top pharmaceutical executives on Thursday, a White House official confirmed. The discussions will focus on Medicare drug price negotiations, pharmacy ...
His proposal could prevent pharmacy benefit managers from inflating medication costs by banning spread pricing.
Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...
President Donald Trump will meet with major drugmakers' executives to discuss drug pricing and insurance changes. Key topics ...
California insurers spent 11% more on pharmaceuticals in 2023 than in 2022 ... who don’t understand drug pricing schemes and restrictions set by pharmacy benefit managers. He’s had to turn away ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results